Siplizumab (Anti-CD2)

Siplizumab (Anti-CD2) is a humanized IgG1 monoclonal antibody targeting CD2. Siplizumab depletes T cells, decreases T cell activation, inhibites T cell proliferation and enriches naïve and bona fide regulatory T cells. MW:145.5 KD.

• Supplier: Selleck Chemicals
• Product #: A2562
• Sku #: A2562-1mg*25